Summary
Dmitry Solodin reviews his portfolio performance, acknowledging excessive concentration in Information Technology and high beta. He outlines plans to reduce risk through trimming positions and using options for protection. He provides detailed views on several individual stocks, favoring mean reversion plays in CRM, Adobe, and Novo Nordisk, while advising to avoid Trade Desk, Palantir, and Doximity due to weak momentum or overvaluation. He also describes a risk-managed SPY strategy with protective puts.
- Portfolio review: heavy overweight in Info Tech created high beta and large drawdowns; he is reducing exposure and aiming for better sector diversification.
- S&P 500 valuation is stretched with negative real earnings yield relative to bonds, raising risks of a correction despite ongoing narrow market strength.
- Mean reversion trades identified: Salesforce (CRM) target 230-240, Adobe (ADBE) target 450, Novo Nordisk (NVO) target 80 after sharp pullbacks.
- Incyte (INCY) shows a bullish cup-and-handle pattern with accelerating fundamentals; he remains long and expects a breakout.
- Stocks to avoid or wait: Trade Desk (TTD) fundamental momentum broken, Palantir (PLTR) extremely overvalued, Doximity (DOCS) weak momentum after AI spike.
- PayPal (PYPL) is at a critical resistance; a breakout could trigger a short squeeze to $80, but confirmation is needed.
- Advocates a disciplined long SPY strategy hedged with rolling protective puts to achieve high Sharpe ratio and limited downside.
- General macro view: cautious on broad market, no new adds, focusing on risk control and mean reversion setups in select names.